Goldstein Keith 4
4 · VerifyMe, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
VerifyMe, Inc.VRME
Goldstein Keith
Chief Operating Officer
Transactions
- Award
Common Stock, par value $0.001 per share
2022-02-28$2.69/sh+5,000$13,450→ 20,000 total
Holdings
- 20,000(indirect: By LLC)
Stock Option (Right to Buy)
Exercise: $9.75Exp: 2026-03-01→ Common Stock, par value $0.001 per share (20,000 underlying) - 51,407
Restricted Stock Units
Exercise: $0.00→ Common Stock, par value $0.001 per share (51,407 underlying) - 20,000(indirect: By LLC)
Stock Option (Right to Buy
Exercise: $10.51Exp: 2026-03-01→ Common Stock, par value $0.001 per share (20,000 underlying) - 40,000(indirect: By LLC)
Stock Option (Right to Buy)
Exercise: $2.00Exp: 2026-03-01→ Common Stock, par value $0.001 per share (40,000 underlying)
Footnotes (4)
- [F1]These shares were acquired under the VerifyMe, Inc. 2021 Stock Purchase Plan in a transaction exempt under Rule 16b-3(d).
- [F2]These restricted stock units, which convert into common stock on a one-for-one basis, vest on 2/16/2024 in two equal tranches, except as otherwise provided in the award notice. Tranch 1 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $5.00 for 20 consecutive trading days, Tranch 1 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days.
- [F3](Continued from footnote 2) Tranch 2 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $7.00 for 20 consecutive trading days, Tranch 2 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days.
- [F4]This option is fully exercisable as of the date of this report.